Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBoth Mounjaro (tirzepatide) and Wegovy (semaglutide) are licensed for adults aged 18 and over only — there is no upper age limit stated in the UK product licences, but a prescriber must judge individual suitability at every age. The lower boundary is absolute: neither medicine is licensed for anyone under 18, regardless of weight or health conditions. Age alone, at either end of the spectrum, does not decide the outcome of a clinical assessment. Mounjaro is licensed for adults with a BMI of 30 or above, or 27 or above alongside a weight-related condition such as high blood pressure or type 2 diabetes. Wegovy carries the same general framing. Whether 19 or 75, a prescriber looks at the full clinical picture, not the birthday, before issuing a prescription — these are prescription-only medicines that require individual assessment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most authoritative starting point on this question is the product licence itself. NICE's appraisal of tirzepatide (TA1026, updated September 2025) and the NHS's patient-facing guidance on tirzepatide both specify that the medicine is for adults, meaning 18 and over. The Wegovy SmPC carries the same restriction. These are not arbitrary administrative lines; the clinical trials that underpinned UK authorisation enrolled adults, so safety and efficacy data simply do not exist for children or adolescents using these specific medicines for weight management. A prescriber issuing either medicine to someone under 18 would be acting outside the licensed indication, which no regulated UK pharmacy should do.
The upper end of the age range is a different matter. Neither licence names a maximum age. NICE TA1026 makes no reference to an upper cut-off, and the same is true of NICE TA875 for semaglutide. If you are wondering whether there is an upper age limit for weight loss injections, the short answer from the licences is no, but that is where the licence ends and clinical judgement begins.
It is also worth noting that lower BMI thresholds apply for adults from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds under current UK guidance, at every age within the adult range.
If you are in your 60s, 70s or beyond and reading this, the honest message is that there is no regulatory rule that disqualifies you. What changes with age is the clinical complexity of the assessment, not the existence of a door to walk through. GLP-1 medicines slow gastric emptying and can interact with other drugs. Older adults are more likely to be taking multiple regular medicines, so a prescriber must check interactions carefully. Kidney function matters too: tirzepatide is not recommended when kidney disease is severe, and the same caution applies to semaglutide, because dehydration from nausea or vomiting in the early weeks can put extra strain on already-reduced renal capacity.
Muscle mass is another consideration. Significant weight loss in older adults carries a greater risk of losing lean tissue alongside fat, which can affect mobility and strength. The prescriber and, ideally, a dietitian will want to see a plan that protects protein intake and includes some resistance activity. None of this is a reason to say no automatically; it is a reason to say not without a proper look. Information on how our clinical team approaches these assessments is on the clinical team page.
If you are exploring the question of age limits for weight loss injections on behalf of a parent or older relative, the same principle applies: the conversation is with a prescriber, not a policy document. Patients in the local area can also find details about weight loss injections in Hadleigh, including how to get started with a consultation close to home.
For anyone approaching 18 who is living with obesity and its associated health conditions, the wait until their 18th birthday is the only legally compliant path in private practice. A GP may explore other avenues for adolescents through specialist paediatric pathways, but that is a separate clinical route. The minimum age to take weight loss injections in the licensed sense is 18, full stop.
Once that threshold is crossed, the same eligibility framework applies as it does to any adult: BMI ≥30, or ≥27 alongside a qualifying condition. An 18-year-old presenting with a BMI of 32 and documented hypertension meets the licensed criteria on paper; whether they are clinically appropriate is still a prescriber's call. That is not a loophole or a hurdle, it is the system working as it should for a prescription medicine. You can read more about how weight loss injections work to prepare for that conversation.
If cost is part of what you are weighing up, the weight loss injections pricing page explains what a legitimate private prescription includes and why the market varies so widely between providers.
The MHRA has been clear that selling these medicines online without a proper clinical assessment is dangerous, and age-related risks are part of why that assessment exists. Fake or improperly sourced pens have been seized in significant numbers across the UK; they carry none of the safety checks a regulated pharmacy applies. The MHRA's Yellow Card service lets patients report suspected counterfeit products or adverse effects, and it is there for a reason. A legitimate service asks about your age (along with your medical history, current medicines and weight) before a prescriber makes any decision. If an online seller does not ask, that is the loudest possible red flag, whatever your age.
This matters more, not less, as patients get older. Interactions between tirzepatide and blood pressure or diabetes medicines are clinically significant, and a prescriber needs to know about them. Curious about how the broader range of options compares? The weight management overview covers how different approaches fit different circumstances, and the FAQs answer some of the most common practical questions patients ask before starting. If you have something specific, the contact page connects you directly with the team. When you are ready, starting a free consultation is the most straightforward next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.